학술논문
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
Document Type
article
Author
Mounira Kharoubi; Mélanie Bézard; Arnault Galat; Fabien Le Bras; Elsa Poullot; Valérie Molinier‐Frenkel; Pascale Fanen; Benoit Funalot; Anissa Moktefi; Jean‐Pascal Lefaucheur; Mukedaisi Abulizi; Jean‐François Deux; François Lemonnier; Soulef Guendouz; Coraline Chalard; Amira Zaroui; Vincent Audard; Emilie Bequignon; Diane Bodez; Emmanuel Itti; Luc Hittinger; Etienne Audureau; Emmanuel Teiger; Silvia Oghina; Thibaud Damy
Source
ESC Heart Failure, Vol 8, Iss 6, Pp 5501-5512 (2021)
Subject
Language
English
ISSN
2055-5822
Abstract
Abstract Aims Cardiac amyloidosis (CA) has a poor prognosis which is aggravated by diagnostic delay. Amyloidosis extracardiac and cardiac events (AECE and ACE) may help improve CA diagnosis and typing. The aim of this study was to compare AECE and ACE between different CA types and assess their relationship with survival. Methods and results This retrospective cohort study conducted in France from June 2008 to May 2019, at the Henry Mondor Hospital. This cohort included 983 patients with CA. Mean age at inclusion was 73.1 ± 11.4 years, 726 (75.1%) were male and the mean body mass index was 24.5 ± 4.1 kg/m2. Among them, 321 had immunoglobulin light chain (AL) amyloidosis, 434 had wild‐type transthyretin (ATTRwt), and 212 had hereditary transthyretin (ATTRv). The first AECE and/or ACE occurred at a mean age of 63 ± 11 years for AL and ATTRv, and 70 ± 12 years for ATTRwt (P